XML 41 R31.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segment Reporting (Tables)
12 Months Ended
Nov. 30, 2019
Segment Reporting [Abstract]  
Summary of Net Revenue, Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense, Income Tax Benefit (Expense), Other Comprehensive Income, and Assets by Segment
The following table shows, by segment: net revenue, cost of sales, operating profit, depreciation and amortization, interest expense, income tax (expense) benefit, other comprehensive loss, and assets for the years ended November 30, 201
9
and 201
8
:
 
   For the years ended November 30, 
   2019   2018 
Net revenue:
    
Umbilical cord blood and cord tissue stem cell service
  $30,991,972   $28,817,872 
PrepaCyte CB
   172,395    104,323 
Public cord blood banking
   652,204    296,295 
  
 
 
   
 
 
 
Total net revenue
  $31,816,571   $29,218,490 
  
 
 
   
 
 
 
Cost of sales:
    
Umbilical cord blood and cord tissue stem cell service
  $8,490,824   $7,744,208 
PrepaCyte CB
   249,487    169,397 
Public cord blood banking
   1,295,864    626,057 
  
 
 
   
 
 
 
Total cost of sales
  $10,036,175   $8,539,662 
  
 
 
   
 
 
 
Operating profit:
    
Umbilical cord blood and cord tissue stem cell service
  $8,152,475   $5,620,394 
PrepaCyte CB
   (113,346   (101,329
Public cord blood banking
   (2,976,423   (329,762
  
 
 
   
 
 
 
Total operating profit
  $5,062,706   $5,189,303 
  
 
 
   
 
 
 
Depreciation and amortization:
    
Umbilical cord blood and cord tissue stem cell service
  $365,057   $281,072 
PrepaCyte CB
   36,254    36,254 
Public cord blood banking
       —   
  
 
 
   
 
 
 
Total depreciation and amortization
  $401,311   $317,326 
  
 
 
   
 
 
 
Interest expense:
    
Umbilical cord blood and cord tissue stem cell service
  $1,703,446   $1,546,900 
PrepaCyte CB
       —   
Public cord blood banking
       —   
  
 
 
   
 
 
 
Total interest expense
  $1,703,446   $1,546,900 
  
 
 
   
 
 
 
Income tax (expense) benefit:
    
 
 
 
Umbilical cord blood and cord tissue stem cell service
  $(1,100,641  $(4,472,504
 
 
 
 
 
 
 
 
 
PrepaCyte CB
       —   
Public cord blood banking
       —   
  
 
 
   
 
 
 
Total income tax (expense) benefit
  $(1,100,641  $(4,472,504
  
 
 
   
 
 
 
Other comprehensive income (loss):
    
Umbilical cord blood and cord tissue stem cell service
  $   $300,119 
PrepaCyte CB
       —   
Public cord blood banking
       —   
 
 
 
 
 
 
 
 
 
Total other comprehensive income (loss)
  $   $300,119 
  
 
 
   
 
 
 
The following table shows the assets by segment as of November 30, 2019 and November 30, 2018:
 
 
 
2019
 
 
2018
 
Assets:
  
   
  
   
Umbilical cord blood and cord tissue stem cell service
  $28,975,002   $26,239,260 
PrepaCyte CB
   289,804    319,802 
Public cord blood banking
   13,621,354    15,831,081 
  
 
 
   
 
 
 
Total assets
  $42,886,160   $42,390,143